Ws Management Lllp Cellectis S.A. Transaction History

Ws Management Lllp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$18.19 - $33.25 $47,275 - $86,416	-2,599 Reduced 4.86%	50,907 $1.03 Million
Q2 2020 Aug 13, 2020	SELL	$8.21 - $21.02 $75,556 - $193,447	-9,203 Reduced 14.68%	53,506 $952,000
Q1 2020 May 13, 2020	SELL	$7.81 - $18.82 $24,617 - $59,320	-3,152 Reduced 4.79%	62,709 $577,000
Q3 2019 Nov 13, 2019	SELL	$10.15 - $16.89 $73,719 - $122,672	-7,263 Reduced 9.93%	65,861 $685,000
Q2 2019 Aug 13, 2019	SELL	$14.6 - $20.6 $126,260 - $178,148	-8,648 Reduced 10.58%	73,124 $1.14 Million
Q1 2019 May 13, 2019	SELL	$15.53 - $19.75 $171,156 - $217,664	-11,021 Reduced 11.88%	81,772 $1.5 Million
Q4 2018 Feb 12, 2019	SELL	$15.58 - $28.41 $946,734 - $1.73 Million	-60,766 Reduced 39.57%	92,793 $1.55 Million
Q2 2018 Aug 13, 2018	BUY	$27.78 - $38.53 $4.27 Million - $5.92 Million	153,559 New	153,559 $4.34 Million

11.2M

2.8K

17.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $82.8M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.